A major hospital advocacy group recently urged congressional advisers to “carefully consider” the potential negative consequences of any new efforts [...] …
Category: Regulatory
A former Pfizer executive and current biopharmaceutical consultant took aim this week at what she called the “poorly managed” 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Health Resources and Services Administration (HRSA) has requested public comment on how petitioners file their initial claims in the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Eligible providers in Florida, Georgia and South Carolina can now immediately enroll in the 340B program without waiting for the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Health Resources and Services Administration (HRSA) held a webinar yesterday to guide hospitals through their annual 340B recertification period, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
With the annual 340B hospital recertification period occurring Aug. 12 to Sept. 9, the Health Resources and Services Administration’s (HRSA’s) [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Federal lawmakers may soon vote on a bipartisan bill to streamline Medicaid enrollment for pediatric providers that would also require [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The federal agency tasked with overseeing the 340B program will review and release some of the 340B-related records the New [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two 340B hospitals urged a federal district court to block drugmaker Johnson & Johnson (J&J) from conducting “unlawfully authorized” audits [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SK Life Science issued a refund notice for an epilepsy drug following a 340B price ceiling recalculation. Multiple drug manufacturers [...] …